ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2017 American Transplant Congress

    Triptolide Alleviating Acute Antibody Mediated Rejection by Inhibition of B Cell Activation in Presensitized Recipients.

    D. Zhao,1 S. Li,1 T. Liao,1 Y. Wei,2 X. Hua,1 F. Han,1 Z. Luo,1 X. Liu,1 Q. Sun.

    1Kidney Transplantation, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; 2Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China

    Backgroud: Acute antibody mediated rejection (AMR), resistant to most anti-rejection therapy, is main cause for renal graft loss. Triptolide(TPL) had been reported as a promising…
  • 2017 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorder: Risk Analysis for Pancreas Transplant Patients.

    E. Minja, T. Dunn, A. Matas, T. Pruett, R. Kandaswamy, E. Finger.

    Dept of Surgery, University of Minnesota, Minneapolis, MN

    Objective: Determine incidence, risk factors, and impact of PTLD in pancreas transplantation (PTx).Methods: Retrospective review of all PTx performed between 7/25/1978 and 12/17/2015 at a…
  • 2017 American Transplant Congress

    Conversion from Tacrolimus-Based to Everolimus-Based Immunosuppressive Therapy 3 Months After Living-Donor Kidney Transplantation: A Randomized-Controlled Clinical Trial.

    D. Hesselink,1 N. Shuker,1 J. Osinga,1 M. Clahsen -van Groningen,2 J. Damman,2 C. Baan,1 J. van de Wetering,1 A. Rowshani,1 J. Kal -van Gestel,1 W. Weimar,1 T. van Gelder,3 R. Bouamar.3

    1Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; 2Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; 3Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

    While conversion from ciclosporin to everolimus is well documented, conversion from tacrolimus has been poorly studied. In this randomized-controlled trial the safety and tolerability of…
  • 2017 American Transplant Congress

    Long Term Outcomes of Adult Kidney Transplants from Small Single Pediatric Donors Are Equivalent to Standard Criteria Donors.

    R. McMillan, K. Gray, T. Khader, A. Jabri, J. Kim, A. Watkins.

    Surgery, Weill Cornell Medicine, New York, NY

    PurposeWe analyzed long term outcomes of adult kidney transplant recipients from single pediatric donors at a large volume center.MethodsA retrospective review of 90 adult kidney…
  • 2017 American Transplant Congress

    Predicting Immunologic Risk for Acute Rejection in Pediatric Liver Transplantation.

    S. Antala, L. Bow, R. Morotti, G. Gan, D. Yanhong, U. Ekong, S. Emre.

    Yale University, New Haven, CT

    Background: Studies in heart, lung, kidney, & liver transplantation (LT) indicate an increased negative impact of antibodies (Ab) to HLA on allograft outcome.Aim: To describe…
  • 2017 American Transplant Congress

    Anti-Angiotensin Type 1 Receptor Antibodies Associate with Rejection in Simultaneous Pancreas and Kidney Transplant and Pancreas Transplant Alone Recipients.

    A. Peng, D. Dafoe, J. Choi, A. Vo, X. Zhang, R. Najjar, E. Huang, S. Jordan.

    Comprehensive Transplant Center, Cedars Sinai Medical Center, Los Angeles, CA

    Background: Anti-angiotensin type 1 receptor antibodies (AT1R Ab) have been found to have a strong association with antibody mediated rejection (Reinsmoen et al, Transpl 2010;…
  • 2017 American Transplant Congress

    Safety and Activity of Anti-C1s Humanized Monoclonal Antibody TNT009 in Late Antibody-Mediated Kidney Allograft Rejection – Results of a First-in-Human Phase 1 Trial.

    F. Eskandary,1 B. Jilma,2 J. Muehlbacher,3 M. Wahrmann,1 H. Regele,4 N. Kozakowski,4 S. Panicker,5 J. Reeve,6 P. Halloran,6 J. Gilbert,5 G. Bohmig.1

    1Department of Medicine III, Medical University Vienna, Vienna, Austria; 2Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria; 3Department of Surgery, Medical University Vienna, Vienna, Austria; 4Department of Clinical Pathology, Medical University Vienna, Vienna, Austria; 5True North Therapeutics Inc., San Frnacisco; 6Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Canada

    Study purpose:The classical pathway (CP) of complement may significantly contribute to antibody-mediated rejection (ABMR). Blockade of CP key component C1 may be a promising strategy…
  • 2017 American Transplant Congress

    Maintenance of the Phenotype and Abundance of Islet-Resident Macrophages Promotes Islet Graft Survival and Appears to Prevent Type 1 Diabetes.

    P. Kyriazis, T. Thornley, K. Agarwal, L. Ma, T. Strom, M. Koulmanda.

    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA

    Immunoregulatory tissue resident macrophage subsets have been reported in skin, heart, lung and adipose tissue.We now demonstrate the existence of a functionally immunoregulatory population of…
  • 2017 American Transplant Congress

    Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

    J. Levitsky,1 T. Whisenant,2 S. Kurian,2 S. Rao,1 A. Demetris,3 M. Abecassis.1

    1Northwestern, Chicago; 2The Scripps Research Institute, San Diego; 3University of Pittsburgh, Pittsburgh

    Background: Biomarker profiles diagnostic of acute rejection (AR) could enhance the diagnosis and management of liver transplant (LT) recipients. Our aim was to identify diagnostic…
  • 2017 American Transplant Congress

    Microarray Analysis of Rejection in Formalin-Fixed Paraffin-Embedded Biopsies: Similarities and Disparities with Conventionally Stabilized Biopsies.

    K. Famulski, J. Revee, P. Halloran.

    Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, AB, Canada

    Despite potential for performing molecular diagnostics on formalin-fixed paraffin embedded (FFPE) biopsies, there has been no systematic comparison of microarray gene expression data obtained from…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences